{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:50Z","timestamp":1790270930833,"version":"4.1.0"},"reference-count":11,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL110841\u201004"],"award-info":[{"award-number":["T32HL110841\u201004"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ceftriaxone\u2010induced immune hemolytic anemia (CIHA) is the second most common cause of drug\u2010induced hemolytic anemia. Prompt recognition of this drug reaction is essential because brisk hemolysis can be deadly. The extent to which ceftriaxone antibodies persist after CIHA is unknown; rechallenging patients who have experienced CIHA is not recommended. We report a case of CIHA in a neurooncology patient, which is the first to show anticeftriaxone antibodies with Rh specificity and persisted for 8 months after the drug reaction. These findings have implications for understanding the mechanism of CIHA.<\/jats:p>","DOI":"10.1002\/pbc.26101","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T18:13:12Z","timestamp":1466014392000},"page":"1852-1855","source":"Crossref","is-referenced-by-count":5,"title":["Unusual serological findings associated with ceftriaxone\u2010induced immune hemolytic anemia in a child with disseminated low\u2010grade glioma"],"prefix":"10.1002","volume":"63","author":[{"given":"L. H.","family":"Pecker","sequence":"first","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"},{"name":"Center for Cancer and Blood Disorders  Washington District of Columbia"},{"name":"Department of Pediatrics George Washington School of Medicine and Health Sciences  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Timsar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics George Washington School of Medicine and Health Sciences  Washington District of Columbia"},{"name":"Department of Pathology George Washington School of Medicine and Health Sciences  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. P.","family":"Pary","sequence":"additional","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Denomme","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratories Blood Center of Wisconsin  Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. R.","family":"Criss","sequence":"additional","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. L. C.","family":"Luban","sequence":"additional","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"},{"name":"Center for Cancer and Blood Disorders  Washington District of Columbia"},{"name":"Department of Pediatrics George Washington School of Medicine and Health Sciences  Washington District of Columbia"},{"name":"Department of Pathology George Washington School of Medicine and Health Sciences  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. I.","family":"Hwang","sequence":"additional","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"},{"name":"Center for Cancer and Blood Disorders  Washington District of Columbia"},{"name":"Department of Pediatrics George Washington School of Medicine and Health Sciences  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C. C.","family":"Wong","sequence":"additional","affiliation":[{"name":"Children's National Health System  Washington District of Columbia"},{"name":"Center for Cancer and Blood Disorders  Washington District of Columbia"},{"name":"Department of Pediatrics George Washington School of Medicine and Health Sciences  Washington District of Columbia"},{"name":"Department of Pathology George Washington School of Medicine and Health Sciences  Washington District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03321.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31291142951.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000181"},{"key":"e_1_2_7_5_1","first-page":"73","article-title":"Drug\u2010induced immune hemolytic anemia","volume":"1","author":"Garratty G.","year":"2009","journal-title":"ASH Educ Program Book"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014548310"},{"key":"e_1_2_7_7_1","article-title":"Successful treatment of life\u2010threatening ceftriaxone\u2010induced hemolysis by plasmapheresis in a 4\u2010year old girl","volume":"49","author":"Doratotaj S","year":"2009","journal-title":"Transfusion"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12729"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000161285.12396.FF"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000094"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1979.19379204205.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1309\/JFJE-VUKN-221T-G6EV"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.26101","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.26101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:13:56Z","timestamp":1695741236000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.26101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,15]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1002\/pbc.26101"],"URL":"https:\/\/doi.org\/10.1002\/pbc.26101","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,15]]}}}